(Go to http://www.financialwire.net/?s=ftrdnwswnd for all of today’s and other featured news.)

May 12, 2010 (FinancialWire) — Solta Medical, Inc. (NASDAQ: SLTM), Alma Lasers Ltd. and Alma Lasers, Inc. said that they have reached an agreement resolving lawsuits involving certain Thermage patents held by Solta Medical.

The lawsuit was originally filed on April 26, 2007 in the U.S. District Court in Delaware by Alma Lasers seeking a declaration that nine Thermage patents were invalid and not infringed.

Solta Medical filed counterclaims alleging that certain Alma systems for non-invasively treating skin infringed 11 of its patents, and sought damages and injunctive relief.

The patents addressed in the lawsuit cover methods and devices for tightening skin and achieving other improvements in skin and tissue structures. Alma subsequently filed counterclaims alleging that all 11 patents, which were asserted were not infringed and were not valid.  

As a result of the agreement, Solta Medical and Alma are dismissing their respective litigation claims and have granted each other a covenant not to sue under certain of their respective patents and patent applications, including all the patents involved in the litigation.

In addition, Alma paid Solta Medical a one time payment of $2.25 million.

Solta Medical excluded from the covenant any rights to utilize monopolar RF that utilizes a passive return electrode. Additional terms of the settlement remain confidential.  

California-based Solta Medical is engaged in the medical aesthetics market. The company offers anti-aging solutions. The company offers products to address a range of skin issues under the Thermage, Fraxel and Isolaz brands.

Illinois-based Alma Lasers is a developer, manufacturer and provider of laser, light-based, radiofrequency and ultrasound devices for aesthetic and medical applications.

Real-time, streaming research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate, courtesy of Stock Smart (at http://investrend.stocksmart.com/ss/html/hpcompany.html).

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (at http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website at http://www.financialwire.net/disclosures.php and http://www.financialwire.net/2010/04/23/safe-harbor/). Additional resources for investors are also accessible via the FinancialWire(tm) website (at http://www.financialwire.net/2010/04/23/investor-resources/). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

[hlmsmlh] [hlthcrdp] [nwdlsldw] [prtnrshpsphs] [ftrdnwswnd] [ltgnltgn]

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.